secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001140361-23-052959
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q3 revenue up 19% to $5.0M; net loss $23.7M on non-cash derivative charges
--------------------------------------------------------------------------------

- Revenue $5.0M (+19% YoY); UltraMist consumables +24% to $3.1M, 62% of revenue.
- Operating loss improved to $0.5M from $2.5M YoY; adjusted EBITDA loss $0.3M vs $2.2M.
- Net loss $23.7M vs $1.1M YoY, driven by non-cash fair value losses on derivative liabilities.
- 55 UltraMist systems sold in Q3 (up from 28 in Q1 and 49 in Q2).
- Gross margin 71% vs 72% YoY, stable despite growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123052959/0001140361-23-052959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123052959/ef20014647_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-052959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer